Comparison of Tumor Markers and Risk of Malignancy Index (RMI) in Borderline OvarianTumors Names of
Ergul Demircivi,
Nisan Helin Donmez,
Nihal Callioglu
et al.
Abstract:Background
Borderline ovarian tumours (BOTs) are non-invasive tumours with low malignancy potential frequently observed in patients of reproductive age. Therefore, preoperative differential diagnosis is important in these patients. In our study, we tried to differentiate benign and borderline ovarian tumours preoperatively using risk of malignancy (RMI) index and tumour markers.
Methods
In our study, we retrospectively compared tumour markers and risk of malignancy index (RMI) of 85 patients aged between 17–… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.